| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.31 | 2e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.3 | 4e-08 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.29 | 5e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-06 |